Where does Lifesci Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lifesci Pharmaceuticals, Inc. ranks #41,422 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lifesci Pharmaceuticals, Inc. hold?

Lifesci Pharmaceuticals, Inc. holds 6 US utility patents granted between 2017 and 2019, spanning 3 technology areas.

What is Lifesci Pharmaceuticals, Inc.'s Innovation Score?

Lifesci Pharmaceuticals, Inc. has an Innovation Score of 27.9 out of 100 (25th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Lifesci Pharmaceuticals, Inc. focus on?

Lifesci Pharmaceuticals, Inc.'s top technology area is C07D (Heterocyclic Compounds) with 6 patents. Grants appear in 3 CPC subclasses total.

Is Lifesci Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Lifesci Pharmaceuticals, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Lifesci Pharmaceuticals, Inc.'s patents?

Lifesci Pharmaceuticals, Inc.'s patents average 26.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lifesci Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Lifesci Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2017–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lifesci ranks #41,422 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.

#41,422
of 49,997 US assignees by volume: 25th percentile
by Innovation Score (27.9/100): 26.3
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R41422 · Foreign Corporation #41,422 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #41,422/49,997
PHOTO-FINISH Lidds AB
CPC-NARROW C07D · 3 areas
INNOV-THIN 27.9/100
CLAIMS-DENSE 26.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Lidds AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Lifesci Pharmaceutic… · this assignee

28
3D Lighting… · lowest

7

What this shows Lifesci's Innovation Score is 27.9/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Lifesci's grants concentrate

Lifesci Pharmaceuticals, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2017. By volume, Lifesci sits between Lidds AB and Lilac Cloud, Inc..

Lidds AB

6
Liebherr-france S…

6
Lier Chemical

6
Life Long Driver

6
Lift Airborne

6
Light Polymers Ho…

6
Light Wave Techno…

6
Lilac Cloud

6
Lifesci Pharmaceu… ◀

6

What this shows Lifesci holds 6 patents at rank #41,347, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lifesci

By rank, the assignees closest to #41,347 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Lifesci's primary technology class.

Lifesci's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Lifesci Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	16.7%
2018	1	16.7%
2019	4	66.7%

Which technologies does Lifesci Pharmaceuticals, Inc. patent most?

C07D - Heterocyclic Compounds 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 3 of 3 technology areas

Where it ranks

Overall rank by patents

#41,422

of 49,997 tracked assignees

Innovation Score

27.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Lifesci Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Lifesci Pharmaceuticals, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #41,422 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lifesci Pharmaceuticals, Inc. against Lidds AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.